Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.08
0.00 (0.00%)
At close: Apr 1, 2025, 4:00 PM
10.10
+0.02 (0.17%)
After-hours: Apr 1, 2025, 4:02 PM EDT

TDAC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022
Period Ending
Sep '24 Dec '23 Dec '22
Selling, General & Admin
0.550.490.07
Operating Expenses
0.550.490.07
Operating Income
-0.55-0.49-0.07
Pretax Income
-0.55-0.49-0.07
Net Income
-0.55-0.49-0.07
Net Income to Common
-0.55-0.49-0.07
Shares Outstanding (Basic)
444
Shares Outstanding (Diluted)
444
EPS (Basic)
-0.14-0.12-0.02
EPS (Diluted)
-0.14-0.12-0.02
EBIT
-0.55-0.49-0.07
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q